Consultation gratuite pour les patients internationaux
Français
WhatsApp [email protected]

Actualités

Autorisations de nouveaux médicaments, recherche et actualités hospitalières en Chine, traduites en anglais, avec des liens vers les sources originales.

Les articles d'actualité sont publiés en anglais, avec un lien vers chaque source originale.

Hôpitaux

Digital intelligence empowers medical visits, creating people-friendly diagnosis and treatment

Beijing Anzhen Hospital is using artificial intelligence to empower smart healthcare, introducing multiple medical robots and online convenience systems to streamline visits and improve diagnosis and treatment…

15 octobre 2026 · People's Daily Health
Politiques de santé

20 Years Since Global Approval of MSD's HPV Vaccine: Multiple Parties Join Forces to Advance HPV Prevention in China

In October 2025, seven departments including the National Disease Control and Prevention Administration jointly issued a notice to include the HPV vaccine in the national immunization program starting November 10, 2025.

14 octobre 2026 · Xinhua Health
Recherche

Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China

Allogeneic CD19 CAR NK-cell therapy was safe and well tolerated in relapsed or refractory systemic lupus erythematosus, with six (67%) of nine patients with more than 12 months' follow-up attaining DORIS remission and…

7 octobre 2026 · PubMed
Recherche

Effect of Chinese medicine compound on intestinal bifidobacteria recovery and CD4+ T-Cell activation in postoperative chemotherapy patients with breast cancer

The traditional Chinese medicine compound effectively maintained intestinal flora balance, promoted beneficial bacterial growth, reduced adverse reactions and offered better therapeutic prospects for breast cancer…

7 octobre 2026 · PubMed
Oncologie

Why Is Ovarian Cancer Often Mistaken for a Stomach Ailment? Lan Chunyan: A Silent Killer That Can Be Prevented and Treated

Over 70 percent of ovarian cancer patients are diagnosed at an advanced stage, making it a "silent killer" that is hard to catch early but can still be prevented and treated, an oncologist told Xinhua.

30 septembre 2026 · Xinhua Health
Recherche

Professor Wu Hao's Team's CHOICE-RCT Study Published in JAMA Neurology—Hearing Intervention Significantly Improves Cognitive Function in the Elderly

The CHOICE-RCT study found that hearing aid intervention significantly increased the proportion of elderly patients with mild cognitive impairment whose cognitive function returned to normal (15.34% vs 2.36%), though it…

29 septembre 2026 · Shanghai Ninth People's Hospital
Recherche

Clinical features and management of GPRC5D-associated adverse events in novel GPRC5D × CD3 bispecific talquetamab-treated relapsed/refractory multiple myeloma patients: the MonumenTAL-1 China cohort experience

The GPRC5D-associated adverse events of talquetamab in Chinese patients with relapsed/refractory multiple myeloma were generally mild, well tolerated, and manageable with supportive care, consistent with the known…

1 septembre 2026 · PubMed
Oncologie

Ovarian cancer 'Chinese protocol' draws overseas patients as multidisciplinary team performs precise 'bomb disposal' for Pakistani patient

A multidisciplinary team at Fudan University Shanghai Cancer Center led by Professor Wu Xiaohua achieved R0 resection in a 60-year-old Pakistani woman with advanced ovarian cancer using a…

29 juillet 2026 · Fudan University Shanghai Cancer Center